Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts

Yen Ling Chen, Ju Chi Liu, Shih Hurng Loh, Cheng Hsien Chen, Chuang Ye Hong, Jin Jer Chen, Tzu Hurng Cheng

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Urotensin II, a cyclic dodecapeptide, has recently been demonstrated to play an important role in cardiac remodeling and fibrosis. Cardiac fibroblast is the cell type known to proliferate during cardiac fibrosis and to produce the excess matrix proteins characteristic of cardiac remodeling. However, the effect of urotensin II on cardiac fibroblast proliferation and the intracellular mechanisms remain to be clarified. Cultured neonatal rat cardiac fibroblasts were stimulated with urotensin II, cell proliferation and the reactive oxygen species generation were examined. We also examined the effects of antioxidant pretreatment on urotensin II-induced cell proliferation, extracellular signal-regulated kinase phosphorylation, and the tyrosine phosphorylation of epidermal growth factor receptor, to elucidate the redox-sensitive pathway in urotensin II-induced cell proliferation. Urotensin II-increased cell proliferation and intracellular reactive oxygen species levels which were inhibited by antioxidants N-acetylcysteine, and the flavin inhibitor diphenyleneiodonium. Urotensin II potently activated the tyrosine phosphorylation of epidermal growth factor receptors and extracellular signal-regulated kinase. Pretreatment of cells with U0126, an inhibitor of the upstream activator of mitogen-activated protein kinase kinase, or with AG1478, a selective epidermal growth factor receptor kinase inhibitor, reduced the urotensin II-increased extracellular signal-regulated kinase phosphorylation. Antioxidants, U0126, and AG1478, all significantly inhibited urotensin II-increased cell proliferation in cardiac fibroblasts. Our data suggest that the redox-sensitive intracellular signaling pathway plays a role in urotensin II-induced proliferation in rat cardiac fibroblasts.

Original languageEnglish
Pages (from-to)24-29
Number of pages6
JournalEuropean Journal of Pharmacology
Volume593
Issue number1-3
DOIs
Publication statusPublished - Sep 28 2008

Fingerprint

Reactive Oxygen Species
Fibroblasts
Cell Proliferation
Extracellular Signal-Regulated MAP Kinases
Phosphorylation
Antioxidants
Epidermal Growth Factor Receptor
Oxidation-Reduction
Tyrosine
Fibrosis
urotensin II
Mitogen-Activated Protein Kinase Kinases
Acetylcysteine

Keywords

  • Epidermal growth factor receptor
  • Extracellular signal-regulated kinase
  • Rat cardiac fibroblasts
  • Urotensin II

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. / Chen, Yen Ling; Liu, Ju Chi; Loh, Shih Hurng; Chen, Cheng Hsien; Hong, Chuang Ye; Chen, Jin Jer; Cheng, Tzu Hurng.

In: European Journal of Pharmacology, Vol. 593, No. 1-3, 28.09.2008, p. 24-29.

Research output: Contribution to journalArticle

Chen, Yen Ling ; Liu, Ju Chi ; Loh, Shih Hurng ; Chen, Cheng Hsien ; Hong, Chuang Ye ; Chen, Jin Jer ; Cheng, Tzu Hurng. / Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. In: European Journal of Pharmacology. 2008 ; Vol. 593, No. 1-3. pp. 24-29.
@article{adcddb76a55b475ca96d3af42580eeab,
title = "Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts",
abstract = "Urotensin II, a cyclic dodecapeptide, has recently been demonstrated to play an important role in cardiac remodeling and fibrosis. Cardiac fibroblast is the cell type known to proliferate during cardiac fibrosis and to produce the excess matrix proteins characteristic of cardiac remodeling. However, the effect of urotensin II on cardiac fibroblast proliferation and the intracellular mechanisms remain to be clarified. Cultured neonatal rat cardiac fibroblasts were stimulated with urotensin II, cell proliferation and the reactive oxygen species generation were examined. We also examined the effects of antioxidant pretreatment on urotensin II-induced cell proliferation, extracellular signal-regulated kinase phosphorylation, and the tyrosine phosphorylation of epidermal growth factor receptor, to elucidate the redox-sensitive pathway in urotensin II-induced cell proliferation. Urotensin II-increased cell proliferation and intracellular reactive oxygen species levels which were inhibited by antioxidants N-acetylcysteine, and the flavin inhibitor diphenyleneiodonium. Urotensin II potently activated the tyrosine phosphorylation of epidermal growth factor receptors and extracellular signal-regulated kinase. Pretreatment of cells with U0126, an inhibitor of the upstream activator of mitogen-activated protein kinase kinase, or with AG1478, a selective epidermal growth factor receptor kinase inhibitor, reduced the urotensin II-increased extracellular signal-regulated kinase phosphorylation. Antioxidants, U0126, and AG1478, all significantly inhibited urotensin II-increased cell proliferation in cardiac fibroblasts. Our data suggest that the redox-sensitive intracellular signaling pathway plays a role in urotensin II-induced proliferation in rat cardiac fibroblasts.",
keywords = "Epidermal growth factor receptor, Extracellular signal-regulated kinase, Rat cardiac fibroblasts, Urotensin II",
author = "Chen, {Yen Ling} and Liu, {Ju Chi} and Loh, {Shih Hurng} and Chen, {Cheng Hsien} and Hong, {Chuang Ye} and Chen, {Jin Jer} and Cheng, {Tzu Hurng}",
year = "2008",
month = "9",
day = "28",
doi = "10.1016/j.ejphar.2008.07.025",
language = "English",
volume = "593",
pages = "24--29",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts

AU - Chen, Yen Ling

AU - Liu, Ju Chi

AU - Loh, Shih Hurng

AU - Chen, Cheng Hsien

AU - Hong, Chuang Ye

AU - Chen, Jin Jer

AU - Cheng, Tzu Hurng

PY - 2008/9/28

Y1 - 2008/9/28

N2 - Urotensin II, a cyclic dodecapeptide, has recently been demonstrated to play an important role in cardiac remodeling and fibrosis. Cardiac fibroblast is the cell type known to proliferate during cardiac fibrosis and to produce the excess matrix proteins characteristic of cardiac remodeling. However, the effect of urotensin II on cardiac fibroblast proliferation and the intracellular mechanisms remain to be clarified. Cultured neonatal rat cardiac fibroblasts were stimulated with urotensin II, cell proliferation and the reactive oxygen species generation were examined. We also examined the effects of antioxidant pretreatment on urotensin II-induced cell proliferation, extracellular signal-regulated kinase phosphorylation, and the tyrosine phosphorylation of epidermal growth factor receptor, to elucidate the redox-sensitive pathway in urotensin II-induced cell proliferation. Urotensin II-increased cell proliferation and intracellular reactive oxygen species levels which were inhibited by antioxidants N-acetylcysteine, and the flavin inhibitor diphenyleneiodonium. Urotensin II potently activated the tyrosine phosphorylation of epidermal growth factor receptors and extracellular signal-regulated kinase. Pretreatment of cells with U0126, an inhibitor of the upstream activator of mitogen-activated protein kinase kinase, or with AG1478, a selective epidermal growth factor receptor kinase inhibitor, reduced the urotensin II-increased extracellular signal-regulated kinase phosphorylation. Antioxidants, U0126, and AG1478, all significantly inhibited urotensin II-increased cell proliferation in cardiac fibroblasts. Our data suggest that the redox-sensitive intracellular signaling pathway plays a role in urotensin II-induced proliferation in rat cardiac fibroblasts.

AB - Urotensin II, a cyclic dodecapeptide, has recently been demonstrated to play an important role in cardiac remodeling and fibrosis. Cardiac fibroblast is the cell type known to proliferate during cardiac fibrosis and to produce the excess matrix proteins characteristic of cardiac remodeling. However, the effect of urotensin II on cardiac fibroblast proliferation and the intracellular mechanisms remain to be clarified. Cultured neonatal rat cardiac fibroblasts were stimulated with urotensin II, cell proliferation and the reactive oxygen species generation were examined. We also examined the effects of antioxidant pretreatment on urotensin II-induced cell proliferation, extracellular signal-regulated kinase phosphorylation, and the tyrosine phosphorylation of epidermal growth factor receptor, to elucidate the redox-sensitive pathway in urotensin II-induced cell proliferation. Urotensin II-increased cell proliferation and intracellular reactive oxygen species levels which were inhibited by antioxidants N-acetylcysteine, and the flavin inhibitor diphenyleneiodonium. Urotensin II potently activated the tyrosine phosphorylation of epidermal growth factor receptors and extracellular signal-regulated kinase. Pretreatment of cells with U0126, an inhibitor of the upstream activator of mitogen-activated protein kinase kinase, or with AG1478, a selective epidermal growth factor receptor kinase inhibitor, reduced the urotensin II-increased extracellular signal-regulated kinase phosphorylation. Antioxidants, U0126, and AG1478, all significantly inhibited urotensin II-increased cell proliferation in cardiac fibroblasts. Our data suggest that the redox-sensitive intracellular signaling pathway plays a role in urotensin II-induced proliferation in rat cardiac fibroblasts.

KW - Epidermal growth factor receptor

KW - Extracellular signal-regulated kinase

KW - Rat cardiac fibroblasts

KW - Urotensin II

UR - http://www.scopus.com/inward/record.url?scp=49749096009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749096009&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2008.07.025

DO - 10.1016/j.ejphar.2008.07.025

M3 - Article

C2 - 18671962

AN - SCOPUS:49749096009

VL - 593

SP - 24

EP - 29

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -